Express News | Voyager Therapeutics : Candidate Vy1706 Demonstrates Significant Reductions of Tau at Low Doses in Nhp Study; Ind & Cta Filings Anticipated in 2026
Express News | Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer's Disease
Not Many Are Piling Into Voyager Therapeutics, Inc. (NASDAQ:VYGR) Stock Yet As It Plummets 29%
Voyager Therapeutics Is Maintained at Buy by Canaccord Genuity
Voyager Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)